(Q77932336)

English

The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies

scientific article published on 01 April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Kyra A Gelderman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Vanessa T Blok

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Gert Jan Fleuren

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Arko Gorter

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

483-493

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950905%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

https://scigraph.springernature.com/pub.10.1038/labinvest.3780441

0 references

Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune evasion of tumor cells using membrane-bound complement regulatory proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

CD55 is over-expressed in the tumour environment

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemistry of complement response on human renal cell carcinoma biopsies

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of thyroid cancer cells by complement-regulatory factors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780441

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77932336&oldid=1751953617"